Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 791Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 24BOEHRINGER INGELHEIM

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

DABIGATRAN ETEXILATE MESYLATE

US Patent Number : 9034822

Drug Substance Claim :

Drug Product Claim :

Application Number : 22512

Patent Use Code : U-1759

Delist Requested :

Patent Use Description : METHOD OF REVERSING TH...

Patent Expiration Date : 2031-01-20

blank

02

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

DABIGATRAN ETEXILATE MESYLATE

US Patent Number : 9034822

Drug Substance Claim :

Drug Product Claim :

Application Number : 22512

Patent Use Code : U-1759

Delist Requested :

Patent Use Description : METHOD OF REVERSING TH...

Patent Expiration Date : 2031-01-20

blank

03

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

DABIGATRAN ETEXILATE MESYLATE

US Patent Number : 9034822

Drug Substance Claim :

Drug Product Claim :

Application Number : 22512

Patent Use Code : U-1759

Delist Requested :

Patent Use Description : METHOD OF REVERSING TH...

Patent Expiration Date : 2031-01-20

blank

04

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

DABIGATRAN ETEXILATE MESYLATE

US Patent Number : 7932273

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 214358

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-09-07

blank

05

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

DABIGATRAN ETEXILATE MESYLATE

US Patent Number : 7932273

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 22512

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-09-07

blank

06

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

DABIGATRAN ETEXILATE MESYLATE

US Patent Number : 7932273

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 22512

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-09-07

blank

07

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

DABIGATRAN ETEXILATE MESYLATE

US Patent Number : 7932273

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 22512

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-09-07

blank

08

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

DABIGATRAN ETEXILATE MESYLATE

US Patent Number : 7932273

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 214358

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-09-07

blank

09

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

DABIGATRAN ETEXILATE MESYLATE

US Patent Number : 7932273

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 214358

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-09-07

blank

10

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

DABIGATRAN ETEXILATE MESYLATE

US Patent Number : 7932273

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 214358

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-09-07

blank